BodyOptimizationBodyOptimization
    Back to Compounds

    What is Cagrilintide?

    Cagrilintide is a synthetic analogue of amylin, a hormone your pancreas releases alongside insulin after meals. Amylin helps regulate appetite, satiety, and post meal blood sugar control, and Cagrilintide is designed to mimic those same signals to improve hunger regulation and metabolic outcomes.

    Mechanisms of Action

    Cagrilintide works through amylin like signaling to influence both appetite and glucose handling:

    • Promotes satiety: Helps you feel full for longer, which naturally reduces calorie intake

    • Slows gastric emptying: Delays stomach emptying to prolong fullness after eating

    • Regulates appetite signaling: Dampens cravings and improves dietary adherence through central appetite pathways

    • Stabilizes blood sugar: Works alongside insulin to smooth post meal glucose swings

    • Complements GLP 1 therapy: Designed to pair well with GLP 1 receptor agonists (ex: semaglutide, liraglutide) for stronger metabolic effects and appetite suppression than either alone

    Benefits

    • Sustainable fat loss support: Helps address hunger driven overeating, improving long term adherence

    • Improved glycemic control: Better post prandial blood sugar management and insulin sensitivity support

    • Appetite suppression: More stable hunger control across the day, fewer cravings

    • Synergy with GLP 1s: Co use with GLP-1s (ex: CagriReta style combinations) is associated with stronger weight loss and glycemic improvements

    Dosing

    Level

    Daily

    Weekly (approx)

    Low

    0.1 mg/day

    ~1 mg/week

    Medium

    0.25 mg/day

    ~2 mg/week

    High

    0.5–1 mg/day or more

    ~3.5–7 mg/week or more

    Notes:

    • Dosing is often adjusted based on response and tolerability

    • Cagrilintide is commonly positioned as a combination add on alongside GLP 1 receptor agonists

    Safety Profile

    Cagrilintide has shown a strong tolerability profile in clinical settings. The most common issues tend to be mild gastrointestinal effects, especially early on:

    • Nausea

    • Constipation

    • General GI discomfort

    Stacking

    Appetite Control

    • Cagrilintide

    • Retatrutide, Tirzepetide, Semaglutide

    Fat Loss Stack

    • Cagrilintide

    • Retatrutide, Tirzepatide, Mazdutide, Semaglutide

    • SLU-PP-332

    • 5-Amino-1MQ

    • L-Carnitine

    • AOD-9604

    Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.

    Cagrilintide

    Cagrilintide

    Peptides
    Fat Loss

    Get Sourcing Info

    Enter your email to receive exclusive sourcing information for this compound.

    Research use only, not for human consumption.

    No spam, unsubscribe anytime.